Every issue cites the paper.
If a protocol appears in PeptoSfera, it's anchored in peer-reviewed literature. We cite the author, the year, the sample size. You read the sentence and know exactly where it came from.
Every Thursday, one molecule. Decoded with the precision of someone who read the original paper and the clarity of someone with nothing to sell. Mechanism, real evidence, regulatory status — and the final verdict.
If a protocol appears in PeptoSfera, it's anchored in peer-reviewed literature. We cite the author, the year, the sample size. You read the sentence and know exactly where it came from.
PeptoSfera has no affiliate links, no commission program, and resells no vials. The subscription is the only source of revenue — and that's what keeps the verdict honest.
No "it depends on your case, talk to your doctor." The literature allows an answer — and PeptoSfera picks a side. Yes, conditional, or no. You pay for the position, not the asterisk.
In July the US opened the door and Brazil closed its own. What the evidence actually shows, why almost all of it is animal — and the final verdict.
Why it appeared in the same ANVISA statement and the same FDA vote. Mechanism, what the literature supports about the combination — and the final verdict.
The only two in this sphere with registration and prescription in Brazil. Mechanism, side-effect profile, what the label authorises — and the case where Semaglutide still wins.
“Most of what's published about peptides in Brazil is an influencer selling an affiliate link. PeptoSfera was born to be the opposite: someone who reads the papers in English, talks to São Paulo's sports physicians, and tells you — in plain language — what's worth running and what's marketing. No broscience. No affiliates. Just science, decoded every Thursday.”